IPO Observation | Jingshi Biotech's Secondary Listing Update: No Commercialized Products, Two Years of Losses near $9 Billion
Recently, Jiangsu Jingshi Biotech Co., Ltd. (hereinafter referred to as \"Jingshi Biotech\") updated its prospectus on October 3 and continued to advance the process of listing on the Hong Kong Stock